EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,674 | +34.6% | 19,830 | +42.0% | 0.01% | +50.0% |
| Q2 2023 | $114,924 | -89.0% | 13,964 | -90.3% | 0.00% | -90.7% |
| Q1 2023 | $1,041,470 | +514.6% | 143,651 | +651.9% | 0.04% | +377.8% |
| Q4 2022 | $169,462 | -79.4% | 19,105 | -71.5% | 0.01% | -71.9% |
| Q3 2022 | $821,000 | +0.7% | 67,033 | -2.7% | 0.03% | -8.6% |
| Q2 2022 | $815,000 | -22.2% | 68,884 | +25.2% | 0.04% | -22.2% |
| Q1 2022 | $1,047,000 | +318.8% | 55,040 | +484.0% | 0.04% | +181.2% |
| Q4 2021 | $250,000 | -88.5% | 9,424 | -81.8% | 0.02% | -92.1% |
| Q1 2021 | $2,171,000 | – | 51,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |